首页> 外文期刊>Journal of Atrial Fibrillation >Incidence and Predictive Factors of Hidden Atrial Fibrillation Detected by Implantable loop Recorder after an Embolic Stroke of Undetermined Source
【24h】

Incidence and Predictive Factors of Hidden Atrial Fibrillation Detected by Implantable loop Recorder after an Embolic Stroke of Undetermined Source

机译:来源不明的栓塞性卒中后植入式记录仪检测到房颤的发生率和预测因素

获取原文
           

摘要

Background: The term embolic stroke of undetermined source (ESUS) has been defined for patients with ischemic strokes, where neither a cardioembolic nor a non-cardiac source can be detected. These patients may have asymptomatic episodes of atrial fibrillation (AF). Prolonged monitoring with implantable loop recorder (ILR) and daily remote interrogation in patients after an ESUS has shown an incidence of AF of about 25%. Aims: The main objective of this study was to analyze the incidence and predictive factors of atrial fibrillation in patients with ESUS who underwent an ILR implantation. Methods: It was a single center study. From June 2013 to January 2017 all consecutive patients with an ESUS, who underwent an ILR implantation searching for hidden AF, were included. Possible predictive factors of AF were also analyzed. Results: 65 patients were included (mean age 65.4?±13.8 years, 55.4% males, mean CHA2DS2VASc score 2.3?± 1.5). After a median follow-up of 17.1?±10.7 months, AF was detected in 19 (29.2%) of patients. Variables associated with AF were: age 65 years (HR 9.45 (CI 95% 1.25-71.34); p= 0.02), CHA2DS2VASC scorea‰¥2 (HR 4.09 (CI 95% 0.93-17.87); p=0,06), left atrial enlargement (HR 2.29 (CI 95% 0.89-5.91); p=0.08) and presence of SVC on 24-hour Holter (HR 4.05 (CI 95% 1.55-10.57); p = 0.004) A cut-point of 0.15% for SVC was identified to predict AF with a sensitivity and specificity of 88.9 and 90%, respectively. A CHA2DS2VASc score 65 years, LA enlargement, CHA2DS2VASC scorea‰¥2 and presence of SVC on 24-hour Holter are predictive factors of AF in patients with ESUS.
机译:背景:术语“不确定来源栓塞性卒中”(ESUS)已为缺血性卒中患者定义,其中无法检测到心脏栓塞或非心脏源性栓塞。这些患者可能出现无症状的心房颤动(AF)。在ESUS术后,患者使用植入式环路记录器(ILR)进行的长时间监测和每日远程询问显示房颤发生率约为25%。目的:本研究的主要目的是分析接受ILR植入的ESUS患者房颤的发生率和预测因素。方法:这是一个单中心研究。从2013年6月至2017年1月,纳入了所有连续的ESUS患者,他们接受了ILR植入以寻找隐藏的AF。房颤的可能的预测因素也进行了分析。结果:共纳入65例患者(平均年龄65.4±13.8岁,男性55.4%,平均CHA2DS2VASc评分2.3±1.5)。在中位随访17.1±10.7个月后,有19名患者(29.2%)被检测出房颤。与AF相关的变量为:年龄> 65岁(HR 9.45(CI 95%1.25-71.34); p = 0.02),CHA2DS2VASC评分≥2(HR 4.09(CI 95%0.93-17.87); p = 0.06) ,左房扩大(HR 2.29(CI 95%0.89-5.91); p = 0.08)和24小时动态心电图上存在SVC(HR 4.05(CI 95%1.55-10.57; p = 0.004)确定SVC的0.15%可以预测AF,其敏感性和特异性分别为88.9和90%。 ESUS患者房颤的CHA2DS2VASc评分65岁,LA增大,CHA2DS2VASC评分≥2和24小时动态心电图上存在SVC是AF的预测因素。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号